Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
SB1 Pharma AB
AB
Bankrupt
Org 5592009954
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2019 · 7 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
SB1 Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2019: 0M
0M
2019
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2019: 0M
0M
2019
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
Income statement
SEK thousands
Item
2023
2022
2021
2020
2019
Revenue
0
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
−7
−66
−60
−69
−36
Depreciation & amort.
−77
−75
−75
−75
−13
EBIT
−84
−141
−135
−144
−49
Net financials
−8
−28
−22
−6
—
Profit before tax
−91
−169
−156
−150
−49
Tax
−0
−0
−0
−0
−0
Net profit
−91
−169
−156
−150
−49
Balance sheet
SEK thousands
Item
2023
2022
2021
2020
2019
Total assets
536
600
847
1 046
792
Equity
−86
−51
116
256
393
Long-term debt
173
203
220
333
0
Short-term debt
449
448
511
456
399
Total debt
622
651
731
789
399
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2019
2023
Equity ratio
−16,0 %
This company
38,2 %
Market median
This company
Market median
142% below market
2019
2023
Return on equity
—
This company
18,4 %
Market median
This company
Market median
2019
2023
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2019
2023
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2019
2023
Debt / equity
—
This company
0,62×
Market median
This company
Market median
2019
2023
Annual reports & filings
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Bolagsverket / SCB · Period 2019-04-01 – 2019-12-31
View
PDF
More on SB1 Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
